Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 22;12(1):4831.
doi: 10.1038/s41598-022-08947-x.

COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study

Affiliations

COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study

Maria Guarino et al. Sci Rep. .

Abstract

Liver transplant (LT) recipients are vulnerable to SARS-CoV-2-infection (COVID-19), due to immunosuppression and comorbidities. This study aimed to evaluate the impact of COVID-19 on LT recipients compared to general population in the Campania region. In this prospective double-centre study, we enrolled all consecutive adult LT recipients with confirmed SARS-CoV-2-infection. Data were collected at diagnosis of COVID-19 and during follow-up and compared with the regional population. Thirty LT recipients (3.28%) developed SARS-CoV-2-infection (76.66% male, median age 62.61 years). Sixteen (53.33%) were symptomatic. Common symptoms were fever, cough, fatigue, and anosmia. Twenty-five (83.33%) were outpatients, 5 (16.66%) required hospitalization (6.66% admitted to Intensive Care Unit, 6.62% developed Acute Respiratory Distress Syndrome and 6.66% died). Immunosuppressors were in 3 (10%) patients. Incidence rate of COVID-19 was similar between LT patients and general population (3.28% vs 4.37%, p = 0.142) with higher rate of symptoms in LT patients (53.33% vs 15.87%, p < 0.000). At univariate analysis, hospitalization and case fatality rates were higher in LT patients compared to general population (16.66% vs 4.54%, p = 0.001; and 6.66% vs 1.76%, p = 0.041, respectively). At multivariable logistic regression analysis, LT patients with COVID-19 were more frequently symptomatic (OR 5.447 [95% CI 2.437-12.177], p < 0.000), whereas hospitalization and death for COVID-19 were not significatively associated with LT condition (p = 0.724 and p = 0.462, respectively) and were comparable with general population. LT is not a risk factor for acquiring COVID-19. Nonetheless, LT patients are more frequently symptomatic, although comparable to the general population for hospitalization rate and mortality.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Major outcomes from COVID-19 in LT patients compared to general population within the same geographical area (univariate analysis).

Similar articles

Cited by

References

    1. https://opendatadpc.maps.arcgis.com/apps/dashboards/b0c68bce2cce478eaac8....
    1. http://www.regione.campania.it/regione/it/la-tua-campania/coronavirus-ky....
    1. Michaels MG, La Hoz RM, Danziger-Isakov L, Blumberg EA, Kumar D, et al. Coronavirus disease 2019: Implications of emerging infections for transplantation. Am. J. Transplant. 2020;20(7):1768–1772. doi: 10.1111/ajt.15832. - DOI - PMC - PubMed
    1. Bhoori S, Rossi RE, Citterio D, Mazzaferro V. COVID-19 in long-term liver transplant patients: Preliminary experience from an Italian transplant centre in Lombardy. Lancet Gastroenterol. Hepatol. 2020;5:532–533. doi: 10.1016/S2468-1253(20)30116-3. - DOI - PMC - PubMed
    1. Fernandez-Ruiz M, Andres A, Loinaz C, Delgado JF, Lopez-Medrano F, et al. COVID-19 in solid organ transplant recipients: A single center case series from Spain. Am. J. Transplant. 2020;20(7):1849–1858. doi: 10.1111/ajt.15929. - DOI - PMC - PubMed